Jarrow Formulas, Inc. and James Gormley of Citizens for Health organized a tactical meeting during Expo East, with the hopes of encouraging industry members to take a stronger stand against the recently proposed guidance on new dietary ingredients (NDIs), and to consider formation of a new trade association. In attendance were some of the industry’s largest and most influential supplement makers, retailers, and raw materials suppliers, as well as interested observers such as the founder of the American Botanical Council.
More than 20,000 industry members headed to Baltimore for the chance to learn and grow at Natural Products Expo East. Once again co-located with All Things Organic-BioFach America, the Organic Summit, and Healthy Baking, the show was held at the Baltimore Convention Center from September 21 to 24.
Dulven, Netherlands—Market research firm Innova Market Insights says the superfruits craze shows no signs of slowing down, as more companies are using such ingredients in a broad range of foods and drinks.
Austin, TX—Renowned in the field of pharmacognosy and a mentor to countless other researchers, Norman R. Farnsworth, Ph.D. passed away at the age of 81 at a Chicago hospital on September 10, after a period of declining health from congestive heart failure and type 2 diabetes lasting several months.
Ojai, CA—As communities struggle to regain a footing after Hurricane Irene and Tropical Storm Lee, Nourish America is providing needed support via $1.5 million in nutritional products donated by various companies. Throughout the Northeast and North Carolina, continuous heavy rain has meant record flooding and widespread evacuations, including a mandatory order for 100,000 to flee in preparation for Lee.
The natural products industry has been dissecting the proposed guidelines for new dietary ingredients (NDIs) since the U.S. Food and Drug Administration (FDA) made them public in July. Last month, WholeFoods explained some of the technical parts of the document and what they could mean for supplement makers. But, there’s another side of the story: the human side, specifically how companies are reacting to the document.
The U.S. Food and Drug Administration (FDA) now has broader authority to levy fees for the re-inspection of imported food. The new fee structure comes as a result of certain sections of the recently passed Food Safety Modernization Act (FSMA), and some parties fear it may result in burdensome fees for small companies and in higher food prices.